Text Size Text Size - Small Text Size - Medium Text Size - Large
SITE MAP   |   GLOSSARY
Stavzor

Resources

American Psychiatric Association
1000 Wilson Boulevard
Colonial Place Three
Suite 1825
Arlington, VA 22209
Call Toll-Free: 1-888-35-PSYCH or 1-888-35-77924
From outside the U.S. and Canada call: 1-703-907-7300

American Neurological Association
5841 Cedar Lake Road
Suite 204
Minneapolis, MN 55416
Phone: 952-545-6284

American Academy of Neurology
1080 Montreal Avenue
Saint Paul, MN 55116
Tel: (800) 879-1960 or (651) 695-2717
Fax: (651) 695-2791

National Alliance on Mental Illness (NAMI)
Colonial Place Three
2107 Wilson Boulevard, Suite 300
Arlington, VA 22201-3042
Toll free 1-800-950-NAMI (6264)
TDD (703) 516-7227

National Institute of Mental Health (NIMH)
Public Information and Communications Branch
6001 Executive Boulevard, Room 8184, MSC 9663
Bethesda, MD 20892-9663
Phone: 301-443-4513
Toll free: 1-866-615-6464
TTY: 301-443-8431
TTY toll free: 866-415-8051
Email: nimhinfo@nih.gov

National Institute of Neurological Disorders and Stroke (NINDS)
NIH Neurological Institute
P.O. Box 5801 Bethesda, MD 20824
Phone: 1-800-352-9424
TTY 301-468-5981

National Foundation for Depressive Illness, Inc. (NAFDI) P.O. Box 2257
New York, NY 10116
Phone: 1-800-239-1265

National Mental Health Association (NMHA)
2001 N Beauregard St, 12th floor
Alexandria, VA 22311
Toll-Free: 1-800-969-NMHA (6642)
Phone: (703) 684-7722;
Fax: (703) 684-5968
E-mail: infoctr@nmha.org

The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
This is the largest bipolar disorder treatment study ever undertaken. Funded by NIMH, the progress of studies involved in this project can be accessed here.

Council for Excellence in Neuroscience Education (CENE)
8420 W Bryn Mawr Avenue, Suite 800
Chicago, IL 60631
847-392-2227

Depression and Bipolar Support Alliance (DBSA)
730 North Franklin Street, Suite 501
Chicago, IL 60610
800-826-3632

Citzens United for Research in Epilepsy
730 N. Franklin St. Suite 404
Chicago, IL, 60610
Phone: 800-765-7118
Phone: 312-255-1801
Fax: 312/255-1809
E-mail: info@CUREepilepsy.org

Epilepsy.com
Online resource provided by the Epilepsy Project

Healthfinder
A guide to medical information on the Internet

Intelihealth
Home to Harvard Medical School health information

Mayo Health
Health and medical information

National Library of Medicine
Official National Institutes of Health site

Reuters HealthOnline
Medical News

AES
American Epilepsy Society

AMA
American Medical Association

Epilepsy Foundation
Research, education, advocacy, and services

FDA
US Food and Drug Administration

JAMA
Journal of American Medical Association

J. Kiffin Penry Epilepsy MiniFellow Network
Physician education programs

Request Samples

Important Safety Information You Should Know about STAVZOR

Liver problems Your doctor should check your liver function before you start taking STAVZOR and at frequent intervals while you're on therapy. If you feel generally ill (malaise), weak, and tired, if your face is swollen and you lose your appetite, and start vomiting, call your doctor immediately.

Pregnancy: Birth defectsWomen who can become pregnant need to know that valproic acid has been associated with birth defects, in particular with spina bifida, a condition in which the baby's spinal canal fails to close. If you are planning to become pregnant, you should discuss the risks of birth defects, along with other possible treatment options, with your doctor. If you do become pregnant while taking STAVZOR, call your doctor immediately.
Read more important safety information about pregnancy.

PancreatitisSome people taking valproate have experienced a serious, life-threatening illness called pancreatitis (inflamed pancreas). If you experience stomach pain, nausea, vomiting, and/or loss of appetite, call your doctor immediately.

Common side effects reported in studies with valproate were nausea, drowsiness, vomiting, and dizziness. These are not all the side effects that may occur. You will find a complete list of side effects in the full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.


Recent Information about Antiepileptic Medications including STAVZOR® (valproic acid) Delayed Release Capsules for any use

For Patients and Caregivers

All antiepileptic medicines, used for any condition, may increase suicidal thoughts or actions in some patients. Pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with the healthcare provider as scheduled. Call the healthcare provider between visits as needed, especially if you have concerns about symptoms.

Watch for and call the healthcare provider right away to report if you or your family member see the appearance or worsening of symptoms of depression, any unusual changes in mood or behavior, or the appearance of suicidal thoughts, behavior, or thoughts about self-harm. Behaviors of concern should be reported immediately to the healthcare provider.

For Healthcare Professionals

All antiepileptic drugs (AEDs), including STAVZOR, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Anyone considering prescribing Stavzor or any other AED must balance their risk of suicidal thoughts and behavior with the risk of untreated illness.

Patients, their caregivers, and families should be informed that AEDs increase the risk of suicidal thoughts and behavior and should be advised of the need to be alert for the emergence or worsening of the signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior or thoughts about self-harm. Behaviors of concern should be reported immediately to healthcare providers.

For medical inquiries specific to Stavzor, please call 1-800-455-8070